Clinical Trial Update: Fluorouracil and Oxaliplatin as First-line for Advanced Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating fluorouracil and oxaliplatin as first-line therapy for advanced pancreatic cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Neoplasms

Drugs mentioned

• fluorouracil and oxaliplatin

Snippet

Sponsor: Instituto do Cancer do Estado de São Paulo | Conditions: Pancreatic Neoplasms | Phase 2 | Status: UNKNOWN